By operating transparently as a public benefit corporation, Mark Cuban Cost Plus Drug Company aims to expand affordable access to medication and help to reshape the $4.1 trillion U.S. health care industry.
By operating transparently as a public benefit corporation, Mark Cuban Cost Plus Drug Company aims to expand affordable access to medication and help to reshape the $4.1 trillion U.S. health care industry.